Zacks.com featured highlights Sterling Infrastructure, BJ's Wholesale, Molina Healthcare and Halozyme

04.06.25 11:08 Uhr

Werte in diesem Artikel
Aktien

250,70 EUR -3,10 EUR -1,22%

Indizes

6.092,2 PKT 67,0 PKT 1,11%

For Immediate ReleaseChicago, IL – June 4, 2025 – The stocks in this week’s article are Sterling Infrastructure, Inc. STRL, BJ's Wholesale Club Holdings, Inc. BJ, Molina Healthcare, Inc. MOH and Halozyme Therapeutics, Inc. HALO.4 Stocks With Strong Interest Coverage Ratios to Buy in June 2025U.S. stocks gained on Monday, marking a positive start to June despite rising global trade concerns. The S&P 500 gained 0.41% to reach 5,935.94, the Nasdaq rose 0.67% to 19,242.61, and the Dow Jones Industrial Average edged up 35.41 points, or 0.08%, to finish at 42,305.48. These gains came as tensions between the United States and China resurfaced, with Beijing rejecting allegations of violating a temporary trade deal and instead accusing Washington of failing to fulfill its part. Looking ahead, market participants are likely to monitor further developments in U.S.-China relations, as any shift could impact market sentiment. An ill-informed investor can lose cash if he wagers on a stock only based on the numbers flashing on a real-time stock screen. A critical analysis of a company’s financial background is a must for a better investment decision, especially at a time when the stock market is juggling myriad issues. Often, investors evaluate a company’s performance by simply looking at its sales and earnings, which sometimes do not reveal the real picture. To be more precise, they do not tell whether a company’s fundamentals are sound enough to meet its financial obligations. Here, the coverage ratio comes into play — the higher the metric, the more efficient an enterprise will be in meeting its financial obligations.Sterling Infrastructure, Inc., BJ's Wholesale Club Holdings, Inc., Molina Healthcare, Inc. and Halozyme Therapeutics, Inc. boast an impressive interest coverage ratio.Why Interest Coverage Ratio?The interest coverage ratio is used to determine how effectively a company can pay interest charges on its debt.Debt, which is crucial to financing operations for the majority of companies, comes at a cost called interest. Interest expense has a direct bearing on the profitability of a company. The company’s creditworthiness depends on how effectively it meets its interest obligations. Therefore, the interest coverage ratio is one of the important criteria to factor in before making any investment decision.Interest Coverage Ratio = Earnings before Interest & Taxes (EBIT) divided by Interest Expense. The interest coverage ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.An interest coverage ratio lower than 1 suggests that the company is unable to fulfill its interest obligations and could default on repaying debt. A company capable of generating earnings well above its interest expense can withstand financial hardships. One should also track the company’s past performance to determine whether the interest coverage ratio has improved or worsened over time.Here are four of the eight stocks that qualified the screening:Sterling Infrastructure, which is engaged in e-infrastructure, transportation and building solutions, carries a Zacks Rank #2 and has a VGM Score of B. Sterling Infrastructure delivered a trailing four-quarter earnings surprise of 11.5%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Sterling Infrastructure’s current financial year earnings per share (EPS) suggests growth of 38.5% from the year-ago period. STRL has risen 68.4% in the past year.BJ's Wholesale Club, a leading operator of membership warehouse clubs, carries a Zacks Rank #2 and has a VGM Score of A. BJ has a trailing four-quarter earnings surprise of 17.7%, on average. The Zacks Consensus Estimate for BJ's Wholesale Club’s current financial year sales and EPS indicates growth of 5.6% and 5.9%, respectively, from the year-ago period. BJ has surged 29.1% in the past year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Molina Healthcare, which provides managed healthcare services under Medicaid and Medicare programs and through state insurance marketplaces, carries a Zacks Rank #2 and has a VGM Score of A. The Zacks Consensus Estimate for Molina Healthcare’s current financial year sales and EPS calls for growth of 8.4% and 7.8%, respectively, from the year-ago period. The stock has declined 3.3% in the past year.Halozyme Therapeutics, a biopharmaceutical company, carries a Zacks Rank #2 and has a VGM Score of A. HALO has a trailing four-quarter earnings surprise of 17.6%, on average.The Zacks Consensus Estimate for Halozyme Therapeutics’ current financial year sales and EPS suggests growth of 22.1% and 23.6%, respectively, from the year-ago period. The stock has risen 25.6% in the past year.You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.Disclosure: Performance information for Zacks’ portfolios and strategies is available at: https://www.zacks.com/performance.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2483514/4-stocks-with-strong-interest-coverage-ratios-to-buy-in-june-2025Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Molina Healthcare, Inc (MOH): Free Stock Analysis Report BJ's Wholesale Club Holdings, Inc. (BJ): Free Stock Analysis Report Halozyme Therapeutics, Inc. (HALO): Free Stock Analysis Report Sterling Infrastructure, Inc. (STRL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Molina Healthcare und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Molina Healthcare

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Molina Healthcare

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Molina Healthcare

Wer­bung

Analysen zu Molina Healthcare

DatumRatingAnalyst
03.06.2019Molina Healthcare OutperformBMO Capital Markets
20.10.2017Molina Healthcare Market PerformBMO Capital Markets
31.05.2017Molina Healthcare SellStifel, Nicolaus & Co., Inc.
05.04.2017Molina Healthcare HoldDeutsche Bank AG
21.03.2017Molina Healthcare Equal WeightBarclays Capital
DatumRatingAnalyst
03.06.2019Molina Healthcare OutperformBMO Capital Markets
20.10.2017Molina Healthcare Market PerformBMO Capital Markets
16.02.2017Molina Healthcare HoldStifel, Nicolaus & Co., Inc.
29.04.2016Molina Healthcare BuyStifel, Nicolaus & Co., Inc.
31.07.2015Molina Healthcare BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.04.2017Molina Healthcare HoldDeutsche Bank AG
21.03.2017Molina Healthcare Equal WeightBarclays Capital
02.11.2015Molina Healthcare Equal WeightBarclays Capital
02.06.2015Molina Healthcare HoldDeutsche Bank AG
13.02.2015Molina Healthcare Equal WeightBarclays Capital
DatumRatingAnalyst
31.05.2017Molina Healthcare SellStifel, Nicolaus & Co., Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Molina Healthcare nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen